AKT/PI3K and ERK/MAPK activation by visfatin/eNAMPT promote proliferation and prevent apoptosis in breast cancer, while AKT and ERK1/2 inhibition abrogated these effects (51). This evidence concerns the gene AKT1 and breast carcinoma.